RNA Clinical Trials Resources

  1. Insights Into Chronic Lymphocytic Leukemia 8/28/2024

    In this FAQ, we delve into various aspects of Chronic Lymphocytic Leukemia (CLL), including its incidence and prevalence, the latest clinical trials, and the development of innovative drug therapies.

  2. 2024 RNA Therapeutics: Advancements And Clinical Trends 8/19/2024

    This resource offers a detailed analysis of the global RNA trial landscape, highlighting the growth in trials, especially in the Asia-Pacific region, which has seen a 26% annual growth rate.

  3. Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024) 8/19/2024

    CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.

  4. Oesophageal Cancer: Global Clinical Trial Landscape (2024) 8/19/2024

    Oesophageal cancer is the 11th most common cancer and the 7th leading cause of cancer deaths, starting in the esophagus. Explore our report to discover the latest in treatments, clinical trials, and future innovations.

  5. FAQs – RNA Therapies – Global Clinical Trials Landscape (2024) 8/19/2024

    Whether you’re a researcher, clinician, or industry professional, our FAQs will equip you with essential knowledge on the advancements and challenges in RNA therapy development.

  6. A Global Trials Overview Of Oesophageal Cancer In 2024 8/19/2024

    This FAQ delves into the latest advancements in the treatment of oesophageal cancer, highlighting cutting-edge drugs, ongoing clinical trials, and their potential to improve patient outcomes.

  7. Strategies For A More Secure Outsourcing Bottom Line 7/9/2024

    A panel of experts from across the pharmaceutical/biopharmaceutical industry recently shared their experiences in mitigating financial risk before partnering with a contract research organization (CRO).

  8. How To Establish Effective, Scalable Drug Safety Ops Across Vendors 7/9/2024

    Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.

  9. Insights into Global Non-Small Cell Lung Cancer Research 7/3/2024

    This FAQ section delves into non-small cell lung cancer (NSCLC) incidence, current trials, innovative drugs, and their effects on patient outcomes.

  10. A Global Overview Of Liver Cancer Clinical Studies 7/3/2024

    This FAQ examines advancements in liver cancer treatment, emphasizing innovative drugs, current clinical trials, and their potential effects on patient outcomes.